Miner2 inhibitors represent a class of chemical compounds that specifically target and inhibit the activity of a protein known as Miner2, which plays a crucial role in various cellular processes. Miner2 is involved in the regulation of metal ion transport and homeostasis, making its inhibitors of particular interest in studies concerning biochemical pathways that rely on these ions. The inhibition of Miner2 can lead to significant alterations in metal ion concentrations within cells, affecting processes such as enzymatic activities, cellular signaling, and structural integrity. These inhibitors often exhibit a high degree of specificity for the Miner2 protein, as they must interfere with the precise binding sites involved in ion translocation or regulatory functions. This specificity often arises from interactions between the inhibitors and the unique structural motifs of Miner2, including metal-binding domains or transmembrane regions responsible for ion passage. Understanding these interactions is critical for studying how Miner2 inhibitors modulate cellular biochemistry in non-biological systems.
Chemically, Miner2 inhibitors may contain functional groups designed to chelate metal ions or disrupt their coordination with the protein. They are often synthesized to possess high affinity for the active or regulatory sites on the protein, with particular attention paid to their ability to influence Miner2's conformational states. Furthermore, the structural design of these inhibitors can affect their stability and reactivity under different environmental conditions, such as changes in pH or temperature, which is crucial in experimental setups. Investigations into Miner2 inhibitors also focus on their ability to selectively inhibit specific isoforms of Miner2, as the protein may exist in multiple variants depending on the organism or tissue type under study. Consequently, Miner2 inhibitors serve as valuable tools in probing the fundamental mechanisms of metal ion transport and its regulation at the molecular level.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D may inhibit CISD3 expression by interfering with RNA polymerase activity, potentially disrupting the transcription of CISD3 mRNA. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin is suggested to inhibit CISD3 expression by inducing DNA damage and triggering cellular stress responses that may downregulate CISD3 transcription. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide may inhibit CISD3 expression by inducing DNA damage and activating stress response pathways, potentially leading to decreased CISD3 transcription. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin could potentially inhibit CISD3 expression by interfering with the binding of transcription factors to the CISD3 gene promoter, reducing its transcription. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin is suggested to inhibit CISD3 expression by inducing DNA damage and triggering cellular stress responses that may downregulate CISD3 transcription. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin may inhibit CISD3 expression by inducing DNA damage and activating stress response pathways, potentially leading to decreased CISD3 transcription. | ||||||
Ellipticine | 519-23-3 | sc-200878 sc-200878A | 10 mg 50 mg | $145.00 $569.00 | 4 | |
Ellipticine could potentially inhibit CISD3 expression by inducing DNA damage and interfering with the function of key transcriptional regulators of CISD3. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Mitomycin C is suggested to inhibit CISD3 expression by inducing DNA damage and triggering cellular stress responses that may downregulate CISD3 transcription. | ||||||
Streptonigrin | 3930-19-6 | sc-500892 sc-500892A | 1 mg 5 mg | $104.00 $364.00 | 1 | |
Streptonigrin may inhibit CISD3 expression by inducing DNA damage and activating stress response pathways, potentially leading to decreased CISD3 transcription. | ||||||
Thiostrepton | 1393-48-2 | sc-203412 sc-203412A | 1 g 5 g | $117.00 $423.00 | 10 | |
Thiostrepton could potentially inhibit CISD3 expression by interfering with the binding of transcription factors to the CISD3 gene promoter, reducing its transcription. | ||||||